Rejection of allogeneic tumor is not determined by host responses to MHC class I molecules and is mediated by CD4−CD8+ T lymphocytes that are not lytic for the tumor

This publication has 27 references indexed in Scilit:

• Why do so many lymphocytes respond to major histocompatibility antigens?
  Published by Elsevier ,2004
• The molecular basis of alloreactivity
  Immunology Today, 1990
• Perspectives on the Role of Mhc Antigens in Normal and Malignant Cell Development
  Advances in Cancer Research, 1989
• Reversal of Oncogenesis by the Expression of a Major Histocompatibility Complex Class I Gene
  Science, 1985
• Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation
  Nature, 1984
• Variation in MHC Antigenic Profiles of Tumor Cells and its Biological Effects
  Immunological Reviews, 1981
• Differential expression of H–2 gene products in tumour cells is associated with their metastatogenic properties
  Nature, 1980
• Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens*
  Immunological Reviews, 1979
• Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies.
  The Journal of Experimental Medicine, 1979
• Specific cytostatic effect of lymph node cells from normal and T cell‐deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor‐bearing mice
  European Journal of Immunology, 1973